Is PATH a good stock to buy? We came across a bullish thesis on UiPath, Inc. on Montana Insights’s Substack by Montana Matos. In this article, we will summarize the bulls’ thesis on PATH. UiPath, Inc.’s share was trading at $10.89 as of April 22nd. PATH’s trailing and forward P/E were 20.94 and 13.12 respectively according to Yahoo Finance.
Photo by Lenny Kuhne on Unsplash
UiPath, Inc. provides an automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States and internationally. PATH is mispriced by the market as a legacy automation vendor at risk of obsolescence from generative AI, but it is enterprise execution infrastructure for the agentic AI era. The bearish narrative assumes LLMs replace RPA, yet UiPath is the orchestration layer connecting AI reasoning with deterministic execution across enterprises.
Read More: 15 AI Stocks That Are Quietly Making Investors Rich
Read More: Undervalued AI Stock Poised For Massive Gains: 10000% Upside Potential
Its Maestro platform provides governance, permissions, auditability, and coordination between agents, bots, and humans, enabling safe AI deployment in regulated industries like banking, healthcare, and insurance.
Rather than being displaced by AI, UiPath becomes more essential as agent adoption rises because enterprises need controlled workflows, compliance, and reliable last-mile execution. Fundamentals support transition, with ARR of about $1.78 billion growing double digits, gross margins near 85 percent, and over 10,800 customers including many Fortune 500 firms. Growth has reaccelerated sequentially, while roughly 950 Maestro pilots indicate a pipeline conversion opportunity not reflected in consensus estimates.
If even a fraction converts into production, ARR could exceed expectations, driving margin expansion and multiple re-rating. The market prices stagnation and substitution risk, but trajectory suggests stabilization and acceleration as agentic workflows expand. With strong cash, improving profitability, and rising enterprise demand for governed AI execution, UiPath is a mispriced infrastructure layer of the AI stack. The gap between perception and reality creates asymmetric upside if execution validates the orchestration thesis, driving multiple expansion as UiPath becomes critical AI infrastructure globally layer framework.
Previously, we covered a bullish thesis on UiPath Inc. (PATH) by Alexandru Dragut in October 2024, which highlighted ARR expansion, enterprise adoption and AI-enabled automation scaling across global customers. PATH’s stock price has depreciated by approximately 13.29% since our coverage. Montana Matos shares a similar view but emphasizes UiPath as enterprise execution infrastructure and orchestration layer in the agentic AI stack rather than standalone RPA growth.
UiPath, Inc. is not on our list of the 40 Most Popular Stocks Among Hedge Funds. As per our database, 45 hedge fund portfolios held PATH at the end of the fourth quarter which was 48 in the previous quarter. While we acknowledge the risk and potential of PATH as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than PATH and that has 10,000% upside potential, check out our report about this cheapest AI stock.
Disclosure: None.
